146 related articles for article (PubMed ID: 30116311)
1. Antitumor necrosis factor-α antibodies as a noveltherapy for hepatocellular carcinoma.
Li W; Jian YB
Exp Ther Med; 2018 Aug; 16(2):529-536. PubMed ID: 30116311
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma.
Wang H; Liu J; Hu X; Liu S; He B
Med Sci Monit; 2016 Oct; 22():3694-3704. PubMed ID: 27739418
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
4. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG
World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
[TBL] [Abstract][Full Text] [Related]
7. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
[TBL] [Abstract][Full Text] [Related]
9. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
[TBL] [Abstract][Full Text] [Related]
10. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice.
Haruki K; Shiba H; Fujiwara Y; Furukawa K; Iwase R; Uwagawa T; Misawa T; Ohashi T; Yanaga K
Surgery; 2013 Sep; 154(3):468-78. PubMed ID: 23972653
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells.
Wang J; Tokoro T; Higa S; Kitajima I
Biol Pharm Bull; 2006 Apr; 29(4):634-9. PubMed ID: 16595893
[TBL] [Abstract][Full Text] [Related]
13. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.
Van den Brande JM; Braat H; van den Brink GR; Versteeg HH; Bauer CA; Hoedemaeker I; van Montfrans C; Hommes DW; Peppelenbosch MP; van Deventer SJ
Gastroenterology; 2003 Jun; 124(7):1774-85. PubMed ID: 12806611
[TBL] [Abstract][Full Text] [Related]
14. CD8
Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
[TBL] [Abstract][Full Text] [Related]
15. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
16. Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition.
Gao L; Wang L; Sun Z; Li H; Wang Q; Yi C; Wang X
Drug Des Devel Ther; 2017; 11():1789-1802. PubMed ID: 28670112
[TBL] [Abstract][Full Text] [Related]
17. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B.
Saitou Y; Shiraki K; Yamanaka T; Miyashita K; Inoue T; Yamanaka Y; Yamaguchi Y; Enokimura N; Yamamoto N; Itou K; Sugimoto K; Nakano T
World J Gastroenterol; 2005 Oct; 11(40):6258-61. PubMed ID: 16419152
[TBL] [Abstract][Full Text] [Related]
19. Activation of human Kupffer cells by thymostimulin (TP-1) to produce cytotoxicity against human hepatocellular cancer.
Balch G; Izzo F; Chiao P; Klostergaard J; Curley SA
Ann Surg Oncol; 1997 Mar; 4(2):149-55. PubMed ID: 9084852
[TBL] [Abstract][Full Text] [Related]
20. NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.
Lu X; Ma P; Shi Y; Yao M; Hou L; Zhang P; Jiang L
Mol Cell Endocrinol; 2015 Feb; 401():1-11. PubMed ID: 25448063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
